September 15, 2016: This trial has been completed. Please stay in touch for information about future trials.
August 17, 2015: Retrotope, Inc. is currently conducting
“A Randomized, Double-Blind, Controlled Study to Assess the Safety, Tolerability, and Pharmacokenetics of RT001 in Patients With Friedreich’s Ataxia”.
or contact us at: firstname.lastname@example.org